Filing Analysis
InfuSystem Holdings, Inc. announced that its Board of Directors has authorized a new stock repurchase program for up to $20 million of its common stock. The program is set to commence on July 1, 2026, and will conclude on June 30, 2028.
📋 Key Facts
- The Board of Directors approved a stock repurchase program of up to $20 million.
- The repurchase period spans two years, from July 1, 2026, to June 30, 2028.
- The announcement was made via a press release furnished under Item 7.01 (Regulation FD).
- The filing was signed by CFO Barry Steele on May 18, 2026.
InfuSystem Holdings, Inc. announced the election of Beverly Huss as the new Chairman of the Board of Directors following its 2026 Annual Meeting of Stockholders.
📋 Key Facts
- Beverly Huss was elected Chairman of the Board on May 11, 2026.
- The election occurred during the first board meeting following the 2026 Annual Meeting of Stockholders.
- The company confirmed there are no related-party transactions or family relationships involving Ms. Huss requiring disclosure under Item 404(a).
InfuSystem Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders, which included the approval of an amendment to the company's 2021 Equity Incentive Plan. Stockholders also elected seven directors and ratified the appointment of Grant Thornton LLP as the independent auditor for the 2026 fiscal year.
📋 Key Facts
- The 2026 Annual Meeting of Stockholders was held on May 11, 2026.
- Stockholders approved the Third Amendment to the 2021 Equity Incentive Plan, increasing the maximum number of shares reserved for issuance to 7,000,000.
- Seven directors were elected to the Board: Kenneth D. Eichenbaum, Paul A. Gendron, Ronald Hundzinski, Beverly A. Huss, Carrie Lachance, Scott Shuda, and Dr. John J. Sviokla.
- Executive compensation was approved on a non-binding, advisory basis with 11,915,842 votes in favor.
- Grant Thornton LLP was ratified as the independent accounting firm for the fiscal year ending December 31, 2026, with overwhelming support (16,604,725 votes for).
InfuSystem Holdings, Inc. reported its financial results for the first quarter of 2026 on May 7, 2026. The announcement was made via a press release furnished under Item 2.02 of the Form 8-K.
📋 Key Facts
- The Company issued a press release reporting Q1 2026 financial results on May 7, 2026.
- The press release is furnished as Exhibit 99.1 to the filing.
- The filing was signed by Barry Steele, the Chief Financial Officer.
InfuSystem Holdings, Inc. announced it will release its first quarter 2026 financial results on May 7, 2026, before the market opens. The company will also host a conference call for investors at 9:00 a.m. Eastern Time on the same day.
📋 Key Facts
- Earnings release date set for Thursday, May 7, 2026.
- Conference call scheduled for May 7, 2026, at 9:00 a.m. ET.
- The filing covers the financial results for the first quarter of 2026.
- The announcement was made via a press release furnished as Exhibit 99.1.
InfuSystem Holdings, Inc. has dismissed Deloitte & Touche LLP and appointed Grant Thornton LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2026. The change followed a competitive selection process conducted by the Audit Committee.
📋 Key Facts
- Deloitte & Touche LLP was dismissed on March 13, 2026.
- Grant Thornton LLP was appointed as the new auditor for the 2026 fiscal year on the same date.
- Deloitte's audit reports for the fiscal years ended December 31, 2025, and 2024, contained no adverse opinions or qualifications.
- There were no disagreements with Deloitte on any matter of accounting principles, practices, or financial statement disclosure during the two most recent fiscal years.
- The company did not consult Grant Thornton on any accounting or auditing matters prior to their appointment.
InfuSystem Holdings, Inc. announced that its President and CEO, Carrie Lachance, and CFO, Barry Steele, will participate in the 38th Annual ROTH Conference on March 23, 2026.
📋 Key Facts
- The company will participate in the 38th Annual ROTH Conference on March 23, 2026.
- Key executives attending include CEO Carrie Lachance and CFO Barry Steele.
- The announcement was made via a press release dated March 16, 2026, furnished under Item 7.01.
InfuSystem Holdings, Inc. furnished an updated investor presentation dated February 27, 2026, under Regulation FD.
📋 Key Facts
- The filing was made on February 27, 2026, under Item 7.01 (Regulation FD Disclosure).
- The primary content is an Investor Presentation attached as Exhibit 99.1.
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
- The report was signed by Barry Steele, the Chief Financial Officer.
InfuSystem Holdings, Inc. reported its financial results for the fourth quarter and full fiscal year 2025. The results were disclosed via a press release on February 24, 2026.
📋 Key Facts
- The filing reports financial results for the fourth quarter and fiscal year ended 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- The press release is included as Exhibit 99.1.
- The report was signed by CFO Barry Steele on February 24, 2026.